Skip to contentI
InfuSystem Holdings, Inc
I
INFUInfuSystem Holdings, Inc Q3 2020 · 10-Q
Revenue$25.13M$25.13M+16.9% vs Q3 2019 Net Income$2.94M$2.94M+159.0% vs Q3 2019 EPS Diluted$0.14$0.14+180.0% vs Q3 2019 Gross Profit$15,122,000+23.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InfuSystem Holdings, Inc · CIK 1337013 · Engraved from SEC EDGAR
Operating Cash Flowderived$8,406,000+61.2% Free Cash Flowderived$8,221,000+100.6% Margins · derivedGross margin60.2%+3.2 pt vs Q3 2019
Operating margin12.9%+5.2 pt vs Q3 2019
Net margin11.7%+6.4 pt vs Q3 2019
ended Sep 30, 2020 · filed Nov 13, 2020 · 44 d after period end